Praxis Precision Medicines (PRAX) Operating Leases (2022 - 2024)
Historic Operating Leases for Praxis Precision Medicines (PRAX) over the last 3 years, with Q4 2024 value amounting to $110000.0.
- Praxis Precision Medicines' Operating Leases fell 9559.12% to $110000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $110000.0, marking a year-over-year decrease of 9559.12%. This contributed to the annual value of $110000.0 for FY2024, which is 9559.12% down from last year.
- According to the latest figures from Q4 2024, Praxis Precision Medicines' Operating Leases is $110000.0, which was down 9559.12% from $436000.0 recorded in Q3 2024.
- Praxis Precision Medicines' Operating Leases' 5-year high stood at $3.5 million during Q4 2022, with a 5-year trough of $110000.0 in Q4 2024.
- In the last 3 years, Praxis Precision Medicines' Operating Leases had a median value of $2.1 million in 2023 and averaged $1.9 million.
- As far as peak fluctuations go, Praxis Precision Medicines' Operating Leases crashed by 2871.43% in 2023, and later tumbled by 9559.12% in 2024.
- Over the past 3 years, Praxis Precision Medicines' Operating Leases (Quarter) stood at $3.5 million in 2022, then fell by 28.71% to $2.5 million in 2023, then tumbled by 95.59% to $110000.0 in 2024.
- Its Operating Leases stands at $110000.0 for Q4 2024, versus $436000.0 for Q3 2024 and $755000.0 for Q2 2024.